Response to Ruggles and Cheung, Re: "Sublingual Estradiol Offers No Apparent Advantage Over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study".
作者信息
Yaish Iris, Greenman Yona, Sofer Yael, Tordjman Karen M
机构信息
Institute of Endocrinology, Metabolism, and Hypertension, The Center for Transgender Health, Tel Aviv-Sourasky Medical Center, Tel Aviv, Israel.
Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
出版信息
Transgend Health. 2024 Oct 9;9(5):460-461. doi: 10.1089/trgh.2024.0105. eCollection 2024 Oct.
Abstract
摘要
相似文献
1
Response to Ruggles and Cheung, Re: "Sublingual Estradiol Offers No Apparent Advantage Over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study".对鲁格尔斯和张的回应，主题：“对于初治的跨性别女性进行性别确认激素治疗，舌下雌二醇与口服雌二醇和醋酸环丙孕酮联合用药相比无明显优势：一项前瞻性试点研究的结果”
Transgend Health. 2024 Oct 9;9(5):460-461. doi: 10.1089/trgh.2024.0105. eCollection 2024 Oct.
2
Re: "Sublingual Estradiol Offers No Apparent Advantage Over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study" by Yaish et al.关于：Yaish等人的“对于未经治疗的跨性别女性进行性别确认激素治疗，舌下雌二醇与口服雌二醇和醋酸环丙孕酮联合用药相比无明显优势：一项前瞻性试点研究的结果”
Transgend Health. 2024 Oct 9;9(5):459. doi: 10.1089/trgh.2024.0048. eCollection 2024 Oct.
3
Sublingual Estradiol Offers No Apparent Advantage Over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study.对于初治的跨性别女性进行性别肯定激素治疗，舌下含服雌二醇与口服雌二醇和醋酸环丙孕酮联合用药相比无明显优势：一项前瞻性试点研究的结果
Transgend Health. 2023 Dec 13;8(6):485-493. doi: 10.1089/trgh.2023.0022. eCollection 2023 Dec.
4
Cyproterone acetate for hirsutism.醋酸环丙孕酮治疗多毛症。
Cochrane Database Syst Rev. 2003;2003(4):CD001125. doi: 10.1002/14651858.CD001125.
5
Early body composition changes in trans women on low-dose estradiol: comparing oral vs sublingual administration using dual energy absorptiometry and bioelectrical impedance analysis.低剂量雌二醇治疗的跨性别女性早期身体成分变化：使用双能吸收法和生物电阻抗分析法比较口服与舌下给药方式
J Sex Med. 2025 Apr 15;22(4):625-635. doi: 10.1093/jsxmed/qdaf005.
6
Combined oral contraceptive pills for treatment of acne.复方口服避孕药治疗痤疮。
Cochrane Database Syst Rev. 2012 Jun 13(6):CD004425. doi: 10.1002/14651858.CD004425.pub5.
7
Combined oral contraceptive pills for treatment of acne.复方口服避孕药治疗痤疮。
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD004425. doi: 10.1002/14651858.CD004425.pub6.
8
Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic Review.孕激素在性别确认激素治疗中的应用：一项系统评价。
Endocr Pract. 2022 Dec;28(12):1244-1252. doi: 10.1016/j.eprac.2022.08.012. Epub 2022 Aug 23.
9
Medical methods for first trimester abortion.医学方法终止早期妊娠。
Cochrane Database Syst Rev. 2022 May 24;5(5):CD002855. doi: 10.1002/14651858.CD002855.pub5.
10
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.用于多囊卵巢综合征不孕女性的中草药
Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD007535. doi: 10.1002/14651858.CD007535.pub3.
本文引用的文献
1
Sublingual Estradiol Offers No Apparent Advantage Over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study.对于初治的跨性别女性进行性别肯定激素治疗，舌下含服雌二醇与口服雌二醇和醋酸环丙孕酮联合用药相比无明显优势：一项前瞻性试点研究的结果
Transgend Health. 2023 Dec 13;8(6):485-493. doi: 10.1089/trgh.2023.0022. eCollection 2023 Dec.
2
Development and Growth of Intracranial Meningiomas in Transgender Women Taking Cyproterone Acetate as Gender-Affirming Progestogen Therapy: A Systematic Review.接受醋酸环丙孕酮作为性别确认孕激素治疗的跨性别女性颅内脑膜瘤的发生与生长：一项系统评价
Transgend Health. 2022 Nov 29;7(6):473-483. doi: 10.1089/trgh.2021.0025. eCollection 2022 Nov.
3
A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas.环丙孕酮与颅内脑膜瘤关联性的系统评价和荟萃分析。
Sci Rep. 2022 Feb 4;12(1):1942. doi: 10.1038/s41598-022-05773-z.
4
Low-Dose Cyproterone Acetate Treatment for Transgender Women.低剂量醋酸环丙孕酮治疗跨性别女性。
J Sex Med. 2021 Jul;18(7):1292-1298. doi: 10.1016/j.jsxm.2021.04.008. Epub 2021 Jun 24.
5
Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases.醋酸环丙孕酮可引发多种急性肝损伤，包括皮质类固醇反应性肝炎：22例报告。
Liver Int. 2016 Feb;36(2):302-10. doi: 10.1111/liv.12899. Epub 2015 Jul 16.
Zotero 插件